Scholars

Research Areas:

Map of Science

Research Areas:

selected publications

(2013). Monitoring the global in vitro activity of ertapenem against Escherichia coli from intra-abdominal infections: SMART 2002-2010. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 41(3), 224-228.
(2013). Toward Improved Surveillance: The Impact of Ventilator-Associated Complications on Length of Stay and Antibiotic Use in Patients in Intensive Care Units. CLINICAL INFECTIOUS DISEASES. 56(4), 471-477.
(2013). Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial. CLINICAL INFECTIOUS DISEASES. 56(2), 236-244.
(2012). A multilevel model of methicillin-resistant Staphylococcus aureus acquisition within the hierarchy of an Australian tertiary hospital. AMERICAN JOURNAL OF INFECTION CONTROL. 40(9), 787-793.
(2012). The Success of Acinetobacter Species; Genetic, Metabolic and Virulence Attributes. PLoS One. 7(10),

(2013). Emergence of bla(OXA-181)-carrying ColE plasmid in Klebsiella pneumoniae in Australia. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 41(3), 294-296.
(2013). Monitoring the global in vitro activity of ertapenem against Escherichia coli from intra-abdominal infections: SMART 2002-2010. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 41(3), 224-228.
(2013). Toward Improved Surveillance: The Impact of Ventilator-Associated Complications on Length of Stay and Antibiotic Use in Patients in Intensive Care Units. CLINICAL INFECTIOUS DISEASES. 56(4), 471-477.
(2013). Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 57(2), 734-744.
(2013). Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial. CLINICAL INFECTIOUS DISEASES. 56(2), 236-244.

Research Areas:

Map of Science

Research Areas:

Clarivate VIVO Sandbox